GB1291214A - Vaccine against typhoid fever and process for the production thereof - Google Patents

Vaccine against typhoid fever and process for the production thereof

Info

Publication number
GB1291214A
GB1291214A GB27578/71A GB2757871A GB1291214A GB 1291214 A GB1291214 A GB 1291214A GB 27578/71 A GB27578/71 A GB 27578/71A GB 2757871 A GB2757871 A GB 2757871A GB 1291214 A GB1291214 A GB 1291214A
Authority
GB
United Kingdom
Prior art keywords
mutants
und
salmonella typhi
production
typhoid vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27578/71A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag GmbH International
Original Assignee
Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten filed Critical Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Publication of GB1291214A publication Critical patent/GB1291214A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB27578/71A 1971-04-29 1971-06-11 Vaccine against typhoid fever and process for the production thereof Expired GB1291214A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH631971A CH542928A (de) 1971-04-29 1971-04-29 Verfahren zur Herstellung einer neuen Typhus-Vakzine

Publications (1)

Publication Number Publication Date
GB1291214A true GB1291214A (en) 1972-10-04

Family

ID=4307668

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27578/71A Expired GB1291214A (en) 1971-04-29 1971-06-11 Vaccine against typhoid fever and process for the production thereof

Country Status (16)

Country Link
JP (1) JPS5522448B1 (cg-RX-API-DMAC7.html)
AT (1) AT304763B (cg-RX-API-DMAC7.html)
AU (1) AU445536B2 (cg-RX-API-DMAC7.html)
BE (1) BE770453A (cg-RX-API-DMAC7.html)
CA (1) CA939608A (cg-RX-API-DMAC7.html)
CH (1) CH542928A (cg-RX-API-DMAC7.html)
DE (1) DE2128626B2 (cg-RX-API-DMAC7.html)
DK (1) DK129244B (cg-RX-API-DMAC7.html)
ES (1) ES392830A1 (cg-RX-API-DMAC7.html)
FR (1) FR2134325B1 (cg-RX-API-DMAC7.html)
GB (1) GB1291214A (cg-RX-API-DMAC7.html)
IT (1) IT1101491B (cg-RX-API-DMAC7.html)
NL (1) NL146385B (cg-RX-API-DMAC7.html)
SE (1) SE397632B (cg-RX-API-DMAC7.html)
SU (1) SU492094A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA714798B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009025000A1 (en) * 2007-08-23 2009-02-26 Indian Institute Of Science Mutated salmonella typhi strain and use thereof in a vaccine

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014015706A2 (pt) * 2011-12-22 2020-10-27 Vaximm Ag método para o cultivo de uma estirpe mutante atenuada de salmonella typhi, estirpe mutante atenuada de salmonella typhi e salmonella typhi ty21a

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009025000A1 (en) * 2007-08-23 2009-02-26 Indian Institute Of Science Mutated salmonella typhi strain and use thereof in a vaccine
US8444999B2 (en) 2007-08-23 2013-05-21 Indian Institute Of Science Mutated Salmonella typhi strain and use thereof in a vaccine

Also Published As

Publication number Publication date
IT7830643A0 (it) 1978-12-06
ZA714798B (en) 1972-04-26
NL146385B (nl) 1975-07-15
NL7109739A (cg-RX-API-DMAC7.html) 1972-10-31
CH542928A (de) 1973-10-15
AT304763B (de) 1973-01-25
DK129244B (da) 1974-09-16
SU492094A3 (ru) 1975-11-15
IT1101491B (it) 1985-09-28
DK129244C (cg-RX-API-DMAC7.html) 1975-02-03
BE770453A (fr) 1972-01-24
JPS5522448B1 (cg-RX-API-DMAC7.html) 1980-06-17
DE2128626A1 (de) 1972-11-02
FR2134325B1 (cg-RX-API-DMAC7.html) 1975-02-07
FR2134325A1 (cg-RX-API-DMAC7.html) 1972-12-08
CA939608A (en) 1974-01-08
SE397632B (sv) 1977-11-14
AU3283071A (en) 1973-03-01
ES392830A1 (es) 1974-12-16
DE2128626C3 (cg-RX-API-DMAC7.html) 1978-03-16
DE2128626B2 (de) 1977-07-28
AU445536B2 (en) 1974-02-21

Similar Documents

Publication Publication Date Title
Kekessy et al. New method for detecting bacteriocin production
Jawetz A pneumotropic Pasteurella of laboratory animals. I. Bacteriological and serological characteristics of the organism
CA971496A (en) Method and composition for emulsifying petroleum products with a view to preparing a culture medium for micro-organisms
Senterfitt et al. Salmonellosis in mice infected with Mycobacterium bovis BCG II. Resistance to infection
US2787576A (en) Attenuating b. abortus and p. multocida
Schütze Studies in B. pestis antigens: Iii. The prophylactic value of the envelope and somatic antigens of B. pestis
Dulaney Microbic dissociation of B. coli-communis
Sickles et al. Action of microorganisms from soil on type-specific and nontype-specific pneumococcus type-I carbohydrates
ES392830A1 (es) Procedimiento para la preparacion de una vacuna oral contrael tifus.
Hajna et al. Salmonella types isolated in Maryland between 1936 and 1943
SU549470A1 (ru) Способ получени живой брюшнотифозной вакцины
SU402539A1 (ru) Способ получения глюкана
Schütze Studies on B. pestis antigens as prophylactic agents
Cowan Variation phenomena in streptococci: further studies on virulence and immunity
Cooley Dissociation of streptococci
Westlund The Incidence of Pneumococcus Types in Pneumonias of Children
Arkwright Expt. I. 6 guinea-pigs recd. S vaccine (53 C.), when tested 0 died.
Siegel In Vitro Cultivation of Mouse Ascites Tumour Cells for Virus–Host Cell Studies
SE7506509L (sv) Forfarande for framstellning av ett nytt antibiotikum kallat a-28086.
GB940058A (en) Improvements in or relating to 1-glutamic acid fermentation
Esposito Agar plaque formation by mouse spleen cells in response to vaccination with Vi antigen and typhoid vaccines
GB1390468A (en) Herpes simplex type 2 virus vaccine and method of production and use
FI51953C (fi) Menetelmä seoksen valmistamiseksi käytettäväksi ymppäysaineena maitoha ppobakteeriviljelmän ja fermentoitujen maitotuotteiden valmistuksessa.
Barnes et al. Spontaneous transformation of pneumococcus Type V to Type II
GB846755A (en) Bovine rhinotracheitis vaccine and methods of production

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years